Cellular and molecular requirements for rejection of B16 melanoma in the setting of regulatory T cell depletion and homeostatic proliferation.
Cellular and molecular requirements for rejection of B16 melanoma in the setting of regulatory T cell depletion and homeostatic proliferation.
复制标题
DOI:
10.4049/jimmunol.1100845
复制
发表时间:
2012-03-15
期刊:
影响因子:
--
通讯作者:
Gajewski TF
中科院分区:
文献类型:
--
作者:
Kline J;Zhang L;Battaglia L;Cohen KS;Gajewski TF
We have recently demonstrated that adoptive transfer of regulatory T cell (Treg) - depleted polyclonal T cells into lymphopenic mice leads to rejection of B16 melanoma, which generated an opportunity to study host requirements for tumor rejection when it effectively occurred. CD8+ T cell priming and tumor rejection required tumor antigen cross-presentation, as evidenced by tumor outgrowth in Kb−/− bone marrow chimeric or B71/2−/− mice. CD4+ T cells were additionally required for optimal tumor control, thought not through classical CD4 “help”, as the frequency of primed CD8+ T cells was similar in the absence of CD4+ T cells, and tumor rejection did not depend upon CD40/CD40L interactions or on IL-2 production by CD4+ T cells. Rather, CD4+ T cells appeared to act at the effector phase of tumor rejection and responded to B16-derived antigens in vitro. At the effector phase, IFN-γ production by transferred T cells, but not host cells, was necessary. IFN-γ acted either on host or tumor cells, and was associated with reduced tumor vascularity. Finally, tumor rejection occurred following transfer of TNF-α, perforin or FasL-deficient T cells. However, perforin/FasL double knockout T cells failed to reject, arguing that that the killing of B16 melanoma cells could occur either via the cytotoxic granule or Fas pathways. Collectively, these results support a model in which host tumor antigen cross-presentation primes adoptively-transferred T cells, which remain functional in the setting of homeostatic proliferation and Treg depletion, and which promote tumor rejection via IFN-γ and lysis via cytotoxic granules and/or FasL.
登录
查看更多内容
影响因子:
56.9
作者:
Morgan, Richard A.;Dudley, Mark E.;Rosenberg, Steven A.
通讯作者:
Rosenberg, Steven A.
影响因子:
11.5
作者:
Kline, Justin;Brown, Ian E.;Gajewski, Thomas F.
通讯作者:
Gajewski, Thomas F.
影响因子:
158.5
作者:
Hunder, Naomi N.;Wallen, Herschel;Yee, Cassian
通讯作者:
Yee, Cassian
影响因子:
32.4
作者:
DIGHE, AS;RICHARDS, E;SCHREIBER, RD
通讯作者:
SCHREIBER, RD
影响因子:
32.4
作者:
Qin, ZH;Blankenstein, T
通讯作者:
Blankenstein, T